Asthma quality-of-care markers using administrative data.
OBJECTIVE
To evaluate the relationship of potential asthma quality-of-care markers to subsequent emergency hospital care.


METHODS
Retrospective administrative database analysis.


METHODS
Managed care organization.


METHODS
Asthmatic patients aged 5 to 56 years of age.


METHODS
None.


RESULTS
Candidate quality measures included one or more or four or more controller medication canisters, a controller/total asthma medication ratio of > or = 0.3 or > or = 0.5, and the dispensing of fewer than six beta-agonist canisters in 2002. Outcome was a 2003 asthma emergency department visit or hospitalization. Multivariable analyses adjusted for age, sex, and year 2002 severity (based on utilization). In the total sample (n = 109,774), one or more controllers (odds ratio, 1.35) and four or more controllers (odds ratio, 1.98) were associated with an increased risk of emergency hospital care, whereas a controller/total asthma medication ratio of > or = 0.5 (odds ratio, 0.73) and the dispensing of fewer than six beta-agonist canisters (odds ratio 0.30) were associated with a decreased risk. After adjustment for baseline severity in the total asthma sample, the controller/total asthma medication ratio (odds ratio, 0.62 to 0.78) and beta-agonist measure (odds ratio, 0.42) were associated with decreased risk, whereas the dispensing of four or more canisters of controller medication was associated with increased risk (odds ratio, 1.33). After stratification by year 2002 beta-agonist use, all of the measures were associated with decreased risk in those who received fewer than six beta-agonist canisters, whereas all of the measures except the medication ratio of > or = 0.5 were associated with increased risk in the cohort who received six or more beta-agonist canisters.


CONCLUSIONS
Controller use and beta-agonist use may function as severity indicators in large populations rather than as asthma quality-of-care markers. A medication ratio of > or = 0.5 appeared to function as the best quality-of-care marker in this study.
Schatz
Michael
M
Department of Allergy, Kaiser-Permanente Medical Center, San Diego, Los Angeles, CA 92111, USA. michael.x.schatz@kp.org
Nakahiro
Randy
R
Crawford
William
W
Mendoza
Guillermo
G
Mosen
David
D
Stibolt
Thomas B
TB
D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000534:rehabilitation* / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D016208:Databases, Factual; D006801:Humans; D008875:Middle Aged; D011787:Quality of Health Care / Q000592:standards*; D012189:Retrospective Studies; D016896:Treatment Outcome
D018927:Anti-Asthmatic Agents